Profound Medical (PROF) Long-Term Deferred Tax (2024 - 2026)

Profound Medical's (PROF) quarterly Long-Term Deferred Tax came in at $68000.0 in Q1 2026, down 21.84% year-on-year from $87000.0 in Q1 2025, and up 3.03% quarter-over-quarter from $66000.0 in Q4 2025.

Profound Medical (PROF) Long-Term Deferred Tax (2024 - 2026) Analysis & Trends

Profound Medical's Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $68000.0 for Q1 2026.

  • On a quarterly basis, Long-Term Deferred Tax fell 21.84% year-over-year to $68000.0 in Q1 2026; TTM through Mar 2026 was $68000.0, a 21.84% decrease from a year earlier, with the FY2025 full-year figure at $66000.0, down 24.14% from the prior year.
  • Long-Term Deferred Tax advanced to $68000.0 in Q1 2026 per PROF's latest filing, from $66000.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $101000.0 in Q2 2025 and bottomed at $66000.0 in Q4 2025.
  • The 3-year median for Long-Term Deferred Tax is $83500.0 (2024), against an average of $81500.0.
  • Across the five-year window, Long-Term Deferred Tax declined 24.14% in 2025 and retreated 21.84% in 2026, its largest moves.
  • Year by year, Long-Term Deferred Tax stood at $87000.0 in 2024, then fell by 24.14% to $66000.0 in 2025, then advanced by 3.03% to $68000.0 in 2026.
  • Per Business Quant, the three latest PROF Long-Term Deferred Tax figures stand at $68000.0 (Q1 2026), $66000.0 (Q4 2025), and $80000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Profound Medical 248.64 Mn 198.34 Mn 3.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 68,000.00
Dec 31, 2025 66,000.00
Sep 30, 2025 80,000.00
Jun 30, 2025 101,000.00
Mar 31, 2025 87,000.00
Dec 31, 2024 87,000.00